The chapter explores the challenges of managing multiple medications and supplements from different physicians, advocating for a future where AI systems can deliver personalized health recommendations based on individual data. It delves into frustrations with FDA regulations, discussions on accredited investors versus an accredited patient program, and the utilization of data and AI for medical risk assessment. Additionally, personal experiences with psychedelics like DMT and ketamine are shared, emphasizing proper dosing and respect for their potency.

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode